Hepatitis B and C and life insurance

Two different viruses, two different assessments

They share a name and little else from an underwriting point of view.

Hepatitis C is now curable in the great majority of cases with a course of direct-acting antiviral treatment. Cure is defined by a sustained absence of the virus in the blood after treatment ends. Where that has been achieved, the infection is genuinely gone.

Hepatitis B more often becomes a long-term infection that is monitored, and sometimes treated, over years. It is managed rather than cured in most chronic cases.

That difference drives everything below.

Hepatitis C after cure

This is a case where the underwriting news is better than most people expect, and where outdated assumptions cost people money.

An applicant with documented sustained cure, several years elapsed, normal liver enzymes and no evidence of liver damage is frequently assessed on reasonable terms, and standard rates are achievable at some insurers.

What underwriters want to see:

Confirmation of the cure, meaning documented undetectable virus at the appropriate interval after treatment finished. This is in your records.

Time since treatment. Insurers generally want a period to pass, and it is usually measured in months to a couple of years rather than longer.

Liver status. This is the part that outlasts the virus. If the infection caused scarring before it was treated, that scarring does not reverse simply because the virus has gone. Underwriters look at fibrosis assessment results, which may come from imaging, elastography or bloodwork-based scores.

Current liver enzymes and whether they have normalized.

Someone cured of hepatitis C with a healthy liver is in a very different position from someone cured with established cirrhosis, even though both are cured.

Hepatitis C not yet treated

Where the infection is present and untreated, underwriters assess viral activity and liver status, and the terms are less favourable.

Insurers are also aware that effective treatment exists. A file showing an untreated chronic infection with no plan in place is assessed differently from one showing treatment scheduled or under way. Whether to pursue treatment is a medical decision entirely between you and your doctor.

Hepatitis B

Assessed on a different set of questions, because the natural history is different.

Whether the infection is active. Chronic hepatitis B moves through phases, and underwriters read the virus levels and liver enzyme results together to establish where things stand.

Whether treatment is required. Some people with chronic hepatitis B need antiviral treatment; others are monitored without it. Being monitored rather than treated is not itself a negative, provided the monitoring is happening and the results are stable.

Liver status. As with hepatitis C, whether damage has occurred is central.

Whether you cleared it. Some people infected as adults clear the virus and retain only antibodies. That situation is generally a minor entry in the file rather than a live condition, and it is worth stating specifically on the application rather than describing yourself broadly as having had hepatitis B.

Regular surveillance. Chronic hepatitis B carries an increased risk of liver cancer, and ongoing screening appears in records. Consistent engagement with it is read favourably.

The liver is the real subject

Once the viral picture is established, underwriters are assessing the liver.

Fibrosis describes scarring, and it is staged. Minimal fibrosis with a cured or controlled infection is a good position.

Cirrhosis is advanced scarring and changes the assessment substantially whichever virus caused it. It brings its own complications and its own monitoring requirements, and fully underwritten coverage becomes harder to obtain.

Liver enzyme results appear in the standard blood panel at a paramedical regardless of what the application says, which means the liver picture is partly verified.

What travels with it

Alcohol use matters more here than almost anywhere else, because alcohol and viral hepatitis both affect the same organ and the combination compounds. See alcohol history.

HIV co-infection is assessed alongside, on the terms in living with HIV.

A history of injection drug use, where relevant, is assessed on its own terms and is covered in substance use and recovery.

Applying

Be specific about which virus, and about status. “Hepatitis” on an application tells an underwriter almost nothing useful.

Have the details: which type, when diagnosed, whether treated and when treatment finished, confirmation of cure where applicable, your most recent liver enzyme and fibrosis results, and whether you are under specialist follow-up.

For a cured hepatitis C infection, make sure the documentation of cure is in your records rather than only asserted on the form. It is the single most valuable item in the file.

Apply fully underwritten. Insurers differ here, particularly on how much time they want after a hepatitis C cure.

The boundary

This page describes how insurance applications are assessed. It is not information about hepatitis, its treatment or its monitoring, and nothing here is a recommendation about care. Those decisions belong with your doctor or hepatologist.